Literature DB >> 9518658

Increased calpain expression in experimental demyelinating optic neuritis: an immunocytochemical study.

D C Shields1, W R Tyor, G E Deibler, N L Banik.   

Abstract

Since calcium activated neutral proteinase (calpain) is present in the central nervous system (CNS) and degrades myelin proteins, this endopeptidase has been suggested to play a role in myelin destruction in demyelinating diseases such as multiple sclerosis (MS). In the present study, calpain immunocytochemical expression was examined in Lewis rats with acute experimental allergic encephalomyelitis (EAE), an animal model for MS and optic neuritis. To identify cells expressing calpain, we labeled rat optic nerve sections for calpain with a polyclonal myelin calpain antibody and with monoclonal antibodies for glial (GFAP, OX42) and inflammatory (CD2, ED2, ED1, IFN-gamma) cell-specific markers. The results showed increased calpain expression in microglia (OX42) and infiltrating macrophages (ED1,2) in EAE compared to normal controls. Astrocytes constitutively expressed calpain in controls and acute EAE. Reactive astrocytes in EAE located in or near inflammatory foci, exhibited markedly increased calpain expression. Most T cells in acute EAE showed low level calpain expression while activated IFN-gamma-producing lymphocytes in inflammatory foci exhibited elevated levels of calpain expression. Thus, our results demonstrate increased calpain expression (at transcriptional and/or translational levels) in a rat model of optic neuritis. A role for calpain in myelin destruction during optic neuritis may be relevant to the pathogenesis of this disorder. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9518658     DOI: 10.1016/s0006-8993(97)01381-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  N-WASP has the ability to compensate for the loss of WASP in macrophage podosome formation and chemotaxis.

Authors:  Beth M Isaac; Dan Ishihara; Leora M Nusblat; Jean-Claude Gevrey; Athanassios Dovas; John Condeelis; Dianne Cox
Journal:  Exp Cell Res       Date:  2010-06-27       Impact factor: 3.905

2.  Calpain inhibition attenuates apoptosis of retinal ganglion cells in acute optic neuritis.

Authors:  Amena W Smith; Arabinda Das; M Kelly Guyton; Swapan K Ray; Baerbel Rohrer; Naren L Banik
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-01       Impact factor: 4.799

3.  A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain.

Authors:  D C Shields; K E Schaecher; T C Saido; N L Banik
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

4.  Inhibition of calpain attenuates encephalitogenicity of MBP-specific T cells.

Authors:  Mary K Guyton; Saurav Brahmachari; Arabinda Das; Supriti Samantaray; Jun Inoue; Mitsuyoshi Azuma; Swapan K Ray; Naren L Banik
Journal:  J Neurochem       Date:  2009-07-17       Impact factor: 5.372

Review 5.  Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration.

Authors:  P S Vosler; C S Brennan; J Chen
Journal:  Mol Neurobiol       Date:  2008-08-07       Impact factor: 5.590

6.  Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats.

Authors:  Arabinda Das; M Kelly Guyton; Amena Smith; Gerald Wallace; Misty L McDowell; Denise D Matzelle; Swapan K Ray; Naren L Banik
Journal:  J Neurochem       Date:  2012-11-22       Impact factor: 5.372

7.  Calpain immunoreactivity and morphological damage in chinchilla inner ears after carboplatin.

Authors:  Lian Ding; Sandra L McFadden; Richard J Salvi
Journal:  J Assoc Res Otolaryngol       Date:  2002-03

8.  Distinct Cytokine and Chemokine Expression in Plasma and Calpeptin-Treated PBMCs of a Relapsing-Remitting Multiple Sclerosis Patient: A Case Report.

Authors:  Raghavendar Chandran; Mollie Capone; Denise Matzelle; Rachel Polcyn; Elizabeth Kau; Azizul Haque; Naren L Banik
Journal:  Neurochem Res       Date:  2018-10-05       Impact factor: 3.996

Review 9.  Visual Dysfunction in Multiple Sclerosis and its Animal Model, Experimental Autoimmune Encephalomyelitis: a Review.

Authors:  Taekyun Shin; Meejung Ahn; Jeongtae Kim; Kyungsook Jung; Changjong Moon; Moon-Doo Kim
Journal:  Mol Neurobiol       Date:  2021-03-20       Impact factor: 5.590

10.  MGMT-Methylation in Non-Neoplastic Diseases of the Central Nervous System.

Authors:  Sarah Teuber-Hanselmann; Karl Worm; Nicole Macha; Andreas Junker
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.